Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Some side effects of breast cancer chemotherapy, like neuropathy and nail loss, can last long after treatment.

Some side effects of breast cancer chemotherapy last longer than others, and patient feedback can help improve care.

Melatonin may protect hair follicle stem cells from damage caused by chemotherapy.

Cutaneous angiosarcomas require a combined treatment approach, but prognosis is generally poor.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

A gene mutation worsens skin irritation in mice due to a lack of certain fats.

The new nanoparticles could improve melanoma treatment by working better than current options.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Paclitaxel and nab-paclitaxel can be safe and effective for advanced gastric cancer patients on hemodialysis.

A protein called PCBP2 controls the production of a hair growth protein by interacting with its genetic message and is linked to hair loss when this control is disrupted.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

ALRN-6924 may prevent hair loss caused by chemotherapy.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Mirex seems to promote a unique group of skin cells different from those affected by another tumor promoter, TPA.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Mitochondrial features can predict colorectal cancer outcomes and improve immunotherapy.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Porocarcinoma generally has low rates of recurrence, spread to lymph nodes, and death.